Table 1.
T cell receptor (TCR) signals influencing T cell subset differentiation and Teff function in type 1 diabetes (T1D).
| T cell subset | TCR Signal Strength | Co-stimulatory Molecule | Cytokine Environment | Transcription Factor | Teff Cytokine | Teff Function |
|---|---|---|---|---|---|---|
| Th1/Tc1 | Strong | CD28 | IL-2, IL-12 | T-bet | IFNγ | Involved in the defense against intracellular pathogens by lysing infected cells and inducing immune effector activation. Critical phenotype for the induction of T1D. |
| Th17 | Moderate | – | IL-1β, IL-6, IL-21, IL-23, TGF-β | RORγt | IL-17A-E, IL-21, IL-22 | Provide defense against extracellular pathogens by recruiting neutrophils and macrophages. Highly proinflammatory. Linked to T1D development. |
| Tfh | Strong | ICOS | IL-6, IL-21 | Bcl-6 | IL-4, IL-21 |
Support B cell activation and Ig affinity maturation in germinal centers. Tfh signatures are observed in both mouse and human T1D. |
|
Treg –Thymic/
Adaptive |
Strong/ Weak |
CD28 | IL-2, TGF-β | Foxp3 | IL-10, IL-35, TGF-β | Dampen T cell responses and prevent autoimmunity via contact dependent and independent mechanisms. Loss of function associated with T1D progression. |
| Tr1 | Weak | Inhibitory Receptors | IL-27, TGF-β | Variable Foxp3 expression |
IL-10 | |
| iTreg | Weak | CD28 | IL-2, TGF-β | Foxp3 | IL-10, IL35, TGF-β |